Renal Cancer - Results from #6940

Renal tumor size is an independent prognostic factor for overall survival in von Hippel-Lindau disease - Abstract May 28, 2014

Bilateral renal cell carcinoma with bilateral synchronous adrenal gland metastases - a case report - Abstract May 28, 2014

Practice patterns for the surgical treatment of T1 renal cell carcinoma: A nationwide population-based register study - Abstract May 28, 2014

Percutaneous nephroscopic resection of pyelocaliceal transitional cell carcinoma in solitary kidney - Abstract May 27, 2014

Tumour characteristics and surgical treatment of renal cell carcinoma in Sweden 2005-2010: A population-based study from the National Swedish Kidney Cancer Register - Abstract May 27, 2014

The use of partial nephrectomy: Results from a contemporary national prospective multicenter study - Abstract May 27, 2014

Advances in renal neoplasia: Recommendations from the 2012 International Society of Urological Pathology Consensus Conference - Abstract May 26, 2014

Diagnostic accuracy of contrast-enhanced ultrasound for renal cell carcinoma: A meta-analysis - Abstract May 26, 2014

Transperitoneal approach versus retroperitoneal approach: A meta-analysis of laparoscopic partial nephrectomy for renal cell carcinoma - Abstract May 26, 2014

Renal cell carcinoma detected by preoperative kidney transplant donor examination: A case report - Abstract May 23, 2014

Impact of renal surgery for cortical neoplasms on lipid metabolism - Abstract May 23, 2014

Salvage surgery after energy ablation for renal masses - Abstract May 23, 2014

Matched pair analysis of laparoscopic versus open radical nephrectomy for the treatment of T3 renal cell carcinoma - Abstract May 23, 2014

How long should we follow the post-transplantation patient after graft loss? A case report of renal cancer in the grafted kidney that occurred 16 years after graft loss - Abstract May 22, 2014

Effects of statins on the prognosis of local and locally advanced renal cell carcinoma following nephrectomy - Abstract May 22, 2014

miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression - Abstract May 21, 2014

Growth kinetics and short term outcomes of cT1b and cT2 renal masses under active surveillance - Abstract May 20, 2014

Axitinib safety in metastatic renal cell carcinoma: Suggestions for daily clinical practice based on case studies - Abstract May 20, 2014

Favorable outcome in elderly Asian patients with metastatic renal cell carcinoma treated with everolimus: The Osaka Urologic Oncology Group - Abstract May 19, 2014

Sorafenib as first- or second-line therapy in patients with metastatic renal cell carcinoma in a community setting - Abstract May 19, 2014

Page 348 of 457